Geopolitical Shifts and AI Investments Dominate Friday’s Financial News
Key Takeaways Former President Trump and Russian President Putin announced an agreement on the Ukraine conflict, with Trump stating the […]
Trump-Putin Summit Concludes Without Ceasefire, Leaders Offer Mixed Assessments Amid Geopolitical Warnings
Key Takeaways No immediate ceasefire was announced following the high-stakes meetings between former U.S. President Donald Trump and Russian President
AI Giants Reshape Strategies Amidst Valuation Surge; US Steel Investigates Fatal Blast
Key Takeaways Meta Platforms (META) has restructured its AI division, establishing Meta Superintelligence Labs to accelerate advanced AI development, which
Brazil Navigates US Tariffs and Pivots to Chinese Auto Investment
Key Takeaways Brazil is actively negotiating with the United States to exempt crucial agricultural exports like beef and coffee from
Mixed Signals on Wall Street: Dow Hits Record While S&P 500 and Nasdaq Pare Gains Amid Inflation Concerns
U.S. stock markets concluded Friday, August 15, 2025, with a mixed performance, as investors navigated a landscape of hotter-than-expected inflation
US Imposes New Tariffs, Economic Data Mixed, and Diplomatic Tensions Rise
Key Takeaways The United States has announced a significant shift in trade policy, publishing detailed tariff codes under Section 232
Mixed Signals on Wall Street: Dow Hits Records, Tech Retreats Amid Inflation Watch
U.S. stock markets experienced a mixed session on Friday, August 15, 2025, as investors navigated a landscape of hotter-than-expected inflation
Trump and Putin Commence High-Stakes Alaska Summit Amid Ukraine War, Sanctions Threat
Key Takeaways U.S. President Donald Trump and Russian President Vladimir Putin have commenced their highly anticipated summit in Anchorage, Alaska,
Pharma Giants Shed $250 Billion Amid Weight-Loss Concerns and Trump Threats; High-Stakes Trump-Putin Meeting Expands
Key Takeaways Novo Nordisk (NVO) and Eli Lilly (LLY) collectively saw their market capitalization plummet by $250 billion on Friday,
Market Movers: Pharma Giants Battle, Geopolitical Tensions Rise, and Energy Sector Expands
Key Takeaways Eli Lilly (LLY) has bolstered its position in the competitive obesity and cardiometabolic drug market, signing a US$1.3